GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 84 filers reported holding GENERATION BIO CO in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,708,733 | -31.2% | 3,617,080 | -0.1% | 0.22% | -22.2% |
| Q2 2023 | $19,911,540 | +27.9% | 3,620,280 | 0.0% | 0.28% | +25.7% |
| Q1 2023 | $15,567,204 | +9.2% | 3,620,280 | -0.2% | 0.23% | +19.6% |
| Q4 2022 | $14,255,210 | -26.0% | 3,627,280 | 0.0% | 0.19% | -31.5% |
| Q3 2022 | $19,261,000 | -19.1% | 3,627,280 | 0.0% | 0.28% | -17.9% |
| Q2 2022 | $23,795,000 | -12.0% | 3,627,280 | -1.5% | 0.34% | +7.0% |
| Q1 2022 | $27,027,000 | -1.4% | 3,682,180 | -4.9% | 0.31% | +11.0% |
| Q4 2021 | $27,416,000 | -55.8% | 3,872,180 | +56.6% | 0.28% | -55.0% |
| Q3 2021 | $61,977,000 | -7.0% | 2,472,180 | -0.2% | 0.63% | -3.4% |
| Q2 2021 | $66,664,000 | -2.1% | 2,478,180 | +3.6% | 0.65% | -9.7% |
| Q1 2021 | $68,110,000 | +3.0% | 2,393,180 | +2.6% | 0.72% | -4.9% |
| Q4 2020 | $66,146,000 | +13.8% | 2,333,180 | +24.1% | 0.76% | -5.6% |
| Q3 2020 | $58,111,000 | +92.2% | 1,880,000 | +30.6% | 0.80% | +87.6% |
| Q2 2020 | $30,240,000 | – | 1,440,000 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $54,309,000 | 9.08% |
| Artal Group S.A. | 2,814,191 | $18,461,000 | 0.99% |
| HighVista Strategies LLC | 248,994 | $1,633,000 | 0.99% |
| Yiheng Capital Management, L.P. | 2,597,631 | $17,040,000 | 0.97% |
| PFM Health Sciences, LP | 2,773,313 | $18,193,000 | 0.69% |
| BVF INC/IL | 1,556,032 | $10,273,000 | 0.50% |
| HARVARD MANAGEMENT CO INC | 510,354 | $3,348,000 | 0.39% |
| Bellevue Group AG | 3,627,280 | $23,795,000 | 0.34% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,897,300 | $19,006,000 | 0.10% |
| Corton Capital Inc. | 15,493 | $102,000 | 0.10% |